Udo Gaipl
Head of Radiation Immunobiology
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Udo Gaipl is the Head of Radiation Immunobiology at Universitätsklinikum Erlangen in Germany. His research focuses on the interactions between radiotherapy, immunotherapy, and tumor microenvironments, with recent publications addressing topics such as glioblastoma cell behavior under chemoradiation and the role of immune cells in tumor immunity. He is also actively engaged in developing novel therapeutic strategies, including radio-immunotherapies and nanoparticle applications in cancer treatment.
Articles (14)
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
We introduce a deep-learning- and a registration-based method for automatically analyzing the spatial distribution of nodal metastases (LNs) in head and neck (H/N) cancer cohorts to inform radiotherapy (RT) target volume design. The two methods are evaluated in a cohort of 193 H/N patients/planning CTs with a total of 449 LNs. In the deep learning method, a previously developed nnU-Net 3D/2D ensemble model is used to autosegment 20 H/N levels, with each LN subsequently being algorithmically assigned to the closest-level autosegmentation. In the nonrigid-registration-based mapping method, LNs are mapped into a calculated template CT representing the cohort-average patient anatomy, and kernel density estimation is employed to estimate the underlying average 3D-LN probability distribution allowing for analysis and visualization without prespecified level definitions. Multireader assessment by three radio-oncologists with majority voting was used to evaluate the deep learning method and obtain the ground-truth distribution. For the mapping technique, the proportion of LNs predicted by the 3D probability distribution for each level was calculated and compared to the deep learning and ground-truth distributions. As determined by a multireader review with majority voting, the deep learning method correctly categorized all 449 LNs to their respective levels. Level 2 showed the highest LN involvement (59.0%). The level involvement predicted by the mapping technique was consistent with the ground-truth distribution (p for difference 0.915). Application of the proposed methods to multicenter cohorts with selected H/N tumor subtypes for informing optimal RT target volume design is promising.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Collaborators (12)
Christoph Alexiou
Else Kröner Fresenius endowed W3 Professorship, Head of SEON
Universitätsklinikum Erlangen
Franz Rödel
Goethe University Frankfurt
Piotr Krzeczyński
Chief Specialist
Łukasiewicz Research Network - Industrial Chemistry Institute
Aleksander Bilewicz
Institute of Nuclear Chemistry and Technology
Aneta Rogalska
associate professor/PhD, DSc
Lodz University of Technology
Lukas Heger
-
Florian Putz
University Hospital Erlangen
Agnieszka Marczak
University of Łódź
Luitpold V. Distel
University Hospital Erlangen
Maksim Ionov
Professor
Lodz University of Technology
Stephan Scheidegger
University of Applied Sciences
ALEXANDRE BARRAS
Institut d'Électronique de Microélectronique et de Nanotechnologie
Make your next move.
Prepare your application
Review drafts before you send them.